AxTalis has managed 150+ projects in Market Access and Medical Affairs.
These projects include in-depth analysis and reporting of pathophysiology, epidemiology, patient & treatment pathways, identification of medical and treatment need, health economic modelling with scenario analysis, budget impact analysis, portfolio analysis and strategic positioning.
In addition to the contacts with clinical experts and patient advocacy groups, AxTalis also has regular interactions with key stakeholders at the Cabinet of Health and Social Affairs, FOD Economy, RIZIV, FAGG and Sick Funds. Key associations that we liaise with include the Belgian Federation of Hospital pharmacists (BVZA-ABPH) and the Belgian Respiratory Society (BeRS).
Finally, it is important to note that AxTalis also plays its role to prove the claimed value through Real World Evidence projects which more often than not, is a key step in solidifying the value that has been created and articulated. We partner with LynxCare, a key driver of the Belgian RWE hub that unifies scientific associations, hospitals and industry to leverage patient data for research and qualitative care.